Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Rating of “Hold” from Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been assigned a consensus rating of “Hold” from the fifteen analysts that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $18.2308.

A number of equities research analysts have weighed in on ACHC shares. Leerink Partners lowered Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 3rd. Jefferies Financial Group lowered Acadia Healthcare to a “hold” rating in a research note on Thursday, January 22nd. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Bank of America cut shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and dropped their target price for the stock from $21.50 to $13.00 in a report on Wednesday, December 3rd. Finally, KeyCorp cut their target price on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 3rd.

Institutional Trading of Acadia Healthcare

A number of hedge funds have recently bought and sold shares of the stock. Allworth Financial LP increased its holdings in shares of Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after acquiring an additional 1,177 shares during the period. EverSource Wealth Advisors LLC boosted its position in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN grew its stake in Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the last quarter. Bayforest Capital Ltd bought a new position in Acadia Healthcare in the fourth quarter worth about $52,000. Finally, Hantz Financial Services Inc. raised its holdings in Acadia Healthcare by 501.9% in the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after purchasing an additional 1,822 shares in the last quarter.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $17.17 on Wednesday. The company has a market capitalization of $1.58 billion, a P/E ratio of 14.68, a P/E/G ratio of 4.94 and a beta of 0.89. The company’s 50-day simple moving average is $14.35 and its two-hundred day simple moving average is $18.50. Acadia Healthcare has a one year low of $11.43 and a one year high of $42.85. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.